Immune reconstitution inflammatory syndrome of Kaposi’s sarcoma in an HIV-infected patient

Beral, 1990, Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection?, Lancet, 335, 123, 10.1016/0140-6736(90)90001-L Patel, 2008, Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003, Ann Intern Med, 148, 728, 10.7326/0003-4819-148-10-200805200-00005 Lin, 2009, Kaposi’s sarcoma in patients with human immunodeficiency virus infection in Taiwan, J Microbiol Immunol Infect, 42, 227 Dal Maso, 2001, Epidemiology of HIV-associated malignancies, Cancer Treat Res, 104, 1, 10.1007/978-1-4615-1601-9_1 Martellotta, 2009, AIDS-related Kaposi’s sarcoma: state of the art and therapeutic strategies, Curr HIV Res, 7, 634, 10.2174/157016209789973619 Hengge, 2002, Update on Kaposi’s sarcoma and other HHV8 associated diseases: part 1. Epidemiology, environmental predispositions, clinical manifestations, and therapy, Lancet Infect Dis, 2, 281, 10.1016/S1473-3099(02)00263-3 Hengge, 2002, Update on Kaposi’s sarcoma and other HHV8 associated diseases: part 2. Pathogenesis, Castleman’s disease, and pleural effusion lymphoma, Lancet Infect Dis, 2, 344, 10.1016/S1473-3099(02)00288-8 Ensoli, 2001, Biology of Kaposi’s sarcoma, Eur J Cancer, 37, 1251, 10.1016/S0959-8049(01)00121-6 Sullivan, 2008, HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease, Clin Infect Dis, 47, 1209, 10.1086/592298 Stebbing, 2003, How does HAART lead to the resolution of Kaposi’s sarcoma?, J Antimicrob Chemother, 51, 1095, 10.1093/jac/dkg199 Leidner, 2005, Recrudescent Kaposi’s sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome, AIDS Patient Care STDS, 19, 635, 10.1089/apc.2005.19.635 Connick, 2004, Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy, Clin Infect Dis, 39, 1852, 10.1086/426078 Feller, 2008, Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report, J Periodontol, 79, 362, 10.1902/jop.2008.070225 Nathan, 2007, Suspected immune reconstitution inflammatory syndrome associated with the proliferation of Kaposi’s sarcoma during HAART, AIDS, 21, 775, 10.1097/QAD.0b013e3280ad3da6 Weir, 1997, Mucosal Kaposi’s sarcoma following protease inhibitor therapy in an HIV-infected patient, AIDS, 11, 1895, 10.1097/00002030-199715000-00022 White, 2000, Quantitation of cell-free and cell-associated Kaposi’s sarcoma-associated herpesvirus DNA by real-time PCR, J Clin Microbiol, 38, 1992, 10.1128/JCM.38.5.1992-1995.2000 Muller, 2010, Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis, Lancet Infect Dis, 10, 251, 10.1016/S1473-3099(10)70026-8 Letang, 2010, Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study, J Acquir Immune Defic Syndr, 53, 589, 10.1097/QAI.0b013e3181bc476f Bower, 2005, Immune reconstitution inflammatory syndrome associated with Kaposi’s sarcoma, J Clin Oncol, 23, 5224, 10.1200/JCO.2005.14.597